人类腺病毒型别监测及COVID-19大流行对报告的影响——美国,2017-2023年
本报告总结2017-2023年美国国家腺病毒型别报告系统(NATRS)被动实验室监测数据,共报告2241份有分型结果的人类腺病毒标本。2017-2019年每年报告389-562份,2020-2023年降至58-356份。六种型别(1-4、7、14型)占分型标本的88.3%,17.0%与暴发相关;2021-2022年肝炎聚集性事件伴随41型报告增加。NATRS报告量自COVID-19大流行后下降,需加强参与以改善循环型别监测。
要点
- 2017-2023年NATRS共报告2241份有分型结果的人类腺病毒标本。
- 六种型别(1-4、7、14型)占分型标本的88.3%,17.0%为暴发相关。
- 2021-2022年肝炎聚集性事件伴随41型报告增加。
核心结论
- NATRS报告量自COVID-19大流行后下降,需加强参与以改善循环人类腺病毒型别监测。
研究设计与样本
- NATRS为被动、基于实验室的监测系统,监测美国人类腺病毒型别流行趋势;本报告总结2017-2023年报告数据。
主要发现
- 2017-2023年共报告2241份有分型结果的人类腺病毒标本。
- 2017-2019年每年报告标本数范围为389-562份;2020-2023年下降至58-356份。
- 2017-2023年六种型别(1-4、7、14型)占分型标本的88.3%。
- 17.0%的标本被识别为暴发相关。
- 2021-2022年肝炎聚集性事件伴随41型报告增加。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Human adenoviruses (HAdVs) are typically associated with mild respiratory illnesses, although severe disease and outbreaks in congregate settings occur. The National Adenovirus Type Reporting System (NATRS) is a passive, laboratory-based surveillance system that monitors trends in circulation of HAdV types in the United States. This report summarizes the distribution of HAdV types reported to NATRS during 2017-2023. During this 7-year period, 2,241 HAdV specimens with typing results were reported to NATRS. The number of specimens with HAdV typing results reported varied annually during 2017-2019 (range = 389-562) and declined during 2020-2023 (range = 58-356). During 2017-2023, six HAdV types (1-4, 7, and 14) accounted for 88.3% of typed specimens reported; 17.0% of specimens were identified as outbreak-related. An increase in type 41 reporting was associated with a hepatitis cluster during 2021-2022. Reporting to NATRS has declined since the COVID-19 pandemic, despite continued HAdV circulation reported through passive laboratory surveillance to the National Respiratory and Enteric Virus Surveillance System. Enhanced participation in NATRS is needed to improve monitoring of circulating HAdV types.
引用
- Abdirizak F, Winn AK, Parikh R, et al. Surveillance of Human Adenovirus Types and the Impact of the COVID-19 Pandemic on Reporting - United States, 2017-2023. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39700057. doi:10.15585/mmwr.mm7350a1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。